Related Experiment Video
Updated: Aug 23, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Comparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates
Serkan Oncü1, Metin Punar, Haluk Eraksoy
1Departments of Infectious Diseases and Clinical Microbiology, Adnan Menderes University Faculty of Medicine, Aydin, Turkey. serkanoncu@hotmail.com
Background:
Streptococcus pneumoniae is a leading pathogen causing pneumonia, meningitis, otitis media, bacteremia and sinusitis resulting in significant morbidity and mortality. We examined in vitro activities of five quinolones in comparison with other antibiotics against 85 invasive pneumococcal isolates.
Methods:
Minimal inhibitory concentrations (MICs) of penicillin G, cefuroxime, azithromycin, clarithromycin, trimethoprim-sulfamethoxazole (SXT), ciprofloxacin, ofloxacin, levofloxacin, trovafloxacin and gemifloxacin were determined using a broth microdilution method.
Results:
The overall rates of resistance to penicillin (46%), cefuroxime (20%), azithromycin (20%), clarithromycin (18%) and SXT (46%) were considerable. Among all of the isolates, 9 isolates (11%) were highly resistant (MIC >/=2 mg/l) and 30 isolates (35%) had intermediate resistance (MIC 0.12- 1.0 mg/l). Of the quinolones gemifloxacin and trovafloxacin had the highest activity. The penicillin resistance status of the isolates did not have any effect on the resistance pattern of new quinolones.
Conclusion:
The new quinolones show great potential in the treatment of invasive infections caused by both penicillin-susceptible and penicillin-resistant pneumococci.
Insights
New quinolones like gemifloxacin and trovafloxacin show high activity against Streptococcus pneumoniae. These antibiotics hold promise for treating invasive pneumococcal infections, even those resistant to penicillin.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Streptococcus pneumoniae causes severe pneumonia and meningitis.
- Invasive pneumococcal infections lead to significant mortality.
- Antibiotic resistance in S. pneumoniae is a growing concern.
Purpose of the Study:
- To evaluate the in vitro activity of five quinolones against invasive pneumococcal isolates.
- To compare the efficacy of new quinolones with existing antibiotics.
- To assess the impact of penicillin resistance on quinolone effectiveness.
Main Methods:
- Broth microdilution method used to determine Minimum Inhibitory Concentrations (MICs).
- Tested antibiotics included penicillin G, cefuroxime, azithromycin, clarithromycin, trimethoprim-sulfamethoxazole (SXT), ciprofloxacin, ofloxacin, levofloxacin, trovafloxacin, and gemifloxacin.
- Eighty-five invasive pneumococcal isolates were analyzed.
Main Results:
- High resistance rates observed for penicillin (46%) and SXT (46%).
- Gemifloxacin and trovafloxacin demonstrated the highest in vitro activity among the tested quinolones.
- Penicillin resistance did not affect the susceptibility patterns to the new quinolones.
Conclusions:
- New quinolones exhibit potent activity against both penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
- Gemifloxacin and trovafloxacin represent promising therapeutic options for invasive pneumococcal diseases.
- Further investigation into novel quinolones is warranted for combating antibiotic resistance.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial DNA Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance